Akero Therapeutics (AKRO) Q4 2024 Earnings

Nov 8Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.05
-0.97
-0.89
-0.81

Details

Expected EPS
-0.878678
Actual EPS
-1.05
Surprise EPS
-0.17
Surprise Percent
-19.5%

Description

⁨Akero Therapeutics⁩ (⁦AKRO⁩) has reported earnings of ⁦-1.05⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts